The CTD dossier owner and manufacturer is a leading conglomerate with a diverse range of business operations across multiple industries. The website is structured to provide detailed financial information through sections like “Annual Report,” “Quarterly Report,” and “Price Sensitive Information,” which include links to various reports from recent years and updates on financial performance, such as notices about bond issuances. The company operates in several key sectors, including textiles, pharmaceuticals, personal protective equipment (PPE), ceramics, information and communication technology (ICT), real estate and trading, media, financial services, energy, and travel and tourism. As the largest entity within its group, the company plays a significant role in driving economic activities and growth across these industries, reflecting its strong market presence and commitment to diversified business interests.

This CTD dossier owner and manufacturer, established in the early 1970s in Southeast Asia, specializes in the production of prescription and over-the-counter medications, as well as food supplements. They offer a comprehensive range of dosage forms, including solids, liquids, and semi-solids. The company has a dedicated beta-lactam facility, specializing in the production of penicillin and cephalosporin antibiotics. Their portfolio encompasses over 200 brands, covering diverse therapeutic areas, with a strong focus on providing high-quality products at affordable prices. The company prioritizes adherence to national and international pharmacopoeia standards, ensuring the safety, efficacy, and quality of all their products. Their commitment to research and development ensures they can continuously meet evolving customer needs.